Test ID: ZMMLS
Antimicrobial Susceptibility, Aerobic Bacteria, MIC
NY State Approved
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Useful For
Suggests clinical disorders or settings where the test may be helpful
Determining the in vitro susceptibility of aerobic bacteria involved in human infections
Reflex Tests
Lists test(s) that may or may not be performed, at an additional charge, depending on the result and interpretation of the initial test(s)
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| BLA | Beta Lactamase | No, (Bill Only) | No |
| KPC1 | KPC PCR | No, (Bill Only) | No |
| HODGB | Carbapenamase-Modified Hodge Test | No, (Bill Only) | No |
| SUS | Susceptibility | No, (Bill Only) | No |
Testing Algorithm
Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
When this test is ordered, the additional tests may be performed and charged.
Antimicrobial agent appropriate to the organism and specimen source will be chosen from the panels listed below.
Gram-negative bacillus: amikacin, ampicillin, ampicillin/sulbactam, cefazolin, cefdinir, cefepime, ceftazidime, ceftriaxone, ciprofloxacin, ertapenem, fosfomycin, gentamicin, levofloxacin, meropenem, nitrofurantoin, piperacillin/tazobactam, ticarcillin/clavulanic acid, tobramycin, and trimethoprim/sulfamethoxazole (TMP/SMX). The 2011 CLSI breakpoints for cephalosporins and carbapenems have been implemented. Confirmation testing for extended spectrum beta-lactamases is performed on Escherichia coli, Klebsiella species, and Proteus mirabilis isolates by request. KPC molecular testing and/or modified Hodge testing are available for individual order.
Staphylococcus species: clindamycin, levofloxacin, linezolid, minocycline, mupirocin, nitrofurantoin, oxacillin, penicillin, rifampin, TMP/SMX, and vancomycin. D-test is performed on all isolates for detection of clindamycin resistance.
Enterococcus species: gentamicin synergy, levofloxacin, linezolid, nitrofurantoin, penicillin, and vancomycin.
Streptococcus species: cefepime, ceftriaxone, erythromycin, levofloxacin, meropenem, penicillin, tetracycline, TMP/SMX, and vancomycin.
Haemophilus species: ampicillin if beta-lactamase negative.
Neisseria gonorrhoeae: cefixime, ceftriaxone ciprofloxacin, tetracycline
Helicobacter pylori: amoxicillin, ciprofloxacin, clarithromycin, metronidazole, tetracycline
For antimicrobial agents not part of above panels: testing is available upon special request at an additional charge per antimicrobial (eg, ceftaroline, colistin, daptomycin, tigecycline).
See the following in Special Instructions:
-Antimicrobial Susceptibility Tests
-Infectious Material
Special Instructions and Forms
Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name
A short description of the method used to perform the test
Minimum Inhibitory Concentration (MIC) by Agar Dilution
Reporting Name
A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Aliases
Lists additional common names for a test, as an aid in searching
Bacterial Susceptibility Testing
Extended Spectrum Beta-Lactamase (ESBL)
MIC (Minimum Inhibitory Concentration)
Minimum Inhibitory Concentration (MIC)
Pneumococcus Susceptibility
Streptococcus pneumoniae Susceptibility
Susceptibility Testing
Linezolid (Zyvox)


